Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Outcomes of Adolescents and Young Adults with AML Treated on Pediatric vs Adult Protocols.
Journal: Blood advances
Published: March 10, 2026
Outcomes of adolescents and young adults with AML treated on pediatric vs adult protocols.
Journal: Blood advances
Published: March 10, 2026
Three-Year Follow-Up of Nivolumab-AVD Versus Brentuximab Vedotin-AVD in Adolescents With Advanced-Stage Classic Hodgkin Lymphoma on S1826.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 09, 2026
Complete remission of relapsed ATXN2L::JAK2 fusion positive anaplastic large cell lymphoma following ruxolitinib monotherapy in a child.
Journal: NPJ precision oncology
Published: July 02, 2025
Less may be enough: a transplant-free future for low-risk relapsed Hodgkin lymphoma.
Journal: Translational pediatrics
Published: May 23, 2025
Venetoclax Alone or in Combination With Chemotherapy in Paediatric and Adolescent/Young Adult Patients With Relapsed/Refractory Acute Myeloid Leukaemia.
Journal: Pediatric blood & cancer
Published: November 14, 2024
Nivolumab+AVD in Advanced-Stage Classic Hodgkin's Lymphoma.
Journal: The New England journal of medicine
Published: October 16, 2024
Venetoclax Combined With Chemotherapy in Pediatric and Adolescent/Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia.
Journal: Pediatric blood & cancer
Published: August 08, 2024
Last Updated: 09/26/2026